Proton pump inhibitors as a possible cause of vitiligo: an in vivo and in vitro study. (15th November 2013)
- Record Type:
- Journal Article
- Title:
- Proton pump inhibitors as a possible cause of vitiligo: an in vivo and in vitro study. (15th November 2013)
- Main Title:
- Proton pump inhibitors as a possible cause of vitiligo: an in vivo and in vitro study
- Authors:
- Shin, J.M.
Lee, J.Y.
Lee, D.Y.
Yoon, T.Y.
Lee, J.C.
Lim, E.H.
Sohn, K.C.
Lee, Y.H.
Im, M.
Seo, Y.J.
Kim, C.D.
Lee, J.H.
Lee, Y. - Abstract:
- <abstract abstract-type="main" id="jdv12317-abs-0001"> <title>Abstract</title> <sec id="jdv12317-sec-0001" sec-type="section"> <title>Background</title> <p>Vitiligo is an acquired depigmentation disorder of melanocytes. Recently, some clinical reports have suggested that proton pump inhibitors (PPIs) may worsen vitiligo, but their effects on melanocytes have yet to be elucidated.</p> </sec> <sec id="jdv12317-sec-0002" sec-type="section"> <title>Objective</title> <p>We investigated the effect of PPIs on melanogenesis <italic>in vivo</italic> and <italic>in vitro</italic>.</p> </sec> <sec id="jdv12317-sec-0003" sec-type="section"> <title>Methods</title> <p>We examined the effect of PPIs on melanogenesis in B16 murine melanoma cells by measuring melanin content and tyrosinase (TYR) activity. TYR and tyrosinase‐related protein‐1 (TRP‐1) were monitored by western blotting. Finally, a PPI was applied to zebrafish embryos to investigate its <italic>in vivo</italic> effect on pigmentation.</p> </sec> <sec id="jdv12317-sec-0004" sec-type="section"> <title>Results</title> <p>In agreement with our clinical experience of worsened vitiligo after PPI treatment, PPIs decreased both melanin content and TYR activity. Western blotting showed that PPIs decreased TYR and TRP‐1 protein levels. In the zebrafish test, PPIs inhibited body pigmentation in a dose‐dependent manner.</p> </sec> <sec id="jdv12317-sec-0005" sec-type="section"> <title>Conclusion</title> <p>These results suggest that the<abstract abstract-type="main" id="jdv12317-abs-0001"> <title>Abstract</title> <sec id="jdv12317-sec-0001" sec-type="section"> <title>Background</title> <p>Vitiligo is an acquired depigmentation disorder of melanocytes. Recently, some clinical reports have suggested that proton pump inhibitors (PPIs) may worsen vitiligo, but their effects on melanocytes have yet to be elucidated.</p> </sec> <sec id="jdv12317-sec-0002" sec-type="section"> <title>Objective</title> <p>We investigated the effect of PPIs on melanogenesis <italic>in vivo</italic> and <italic>in vitro</italic>.</p> </sec> <sec id="jdv12317-sec-0003" sec-type="section"> <title>Methods</title> <p>We examined the effect of PPIs on melanogenesis in B16 murine melanoma cells by measuring melanin content and tyrosinase (TYR) activity. TYR and tyrosinase‐related protein‐1 (TRP‐1) were monitored by western blotting. Finally, a PPI was applied to zebrafish embryos to investigate its <italic>in vivo</italic> effect on pigmentation.</p> </sec> <sec id="jdv12317-sec-0004" sec-type="section"> <title>Results</title> <p>In agreement with our clinical experience of worsened vitiligo after PPI treatment, PPIs decreased both melanin content and TYR activity. Western blotting showed that PPIs decreased TYR and TRP‐1 protein levels. In the zebrafish test, PPIs inhibited body pigmentation in a dose‐dependent manner.</p> </sec> <sec id="jdv12317-sec-0005" sec-type="section"> <title>Conclusion</title> <p>These results suggest that the functional inhibition of melanization by PPIs may induce or aggravate vitiligo lesions in genetically predisposed patients.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of the European Academy of Dermatology and Venereology. Volume 28:Number 11(2014:Nov.)
- Journal:
- Journal of the European Academy of Dermatology and Venereology
- Issue:
- Volume 28:Number 11(2014:Nov.)
- Issue Display:
- Volume 28, Issue 11 (2014)
- Year:
- 2014
- Volume:
- 28
- Issue:
- 11
- Issue Sort Value:
- 2014-0028-0011-0000
- Page Start:
- 1475
- Page End:
- 1479
- Publication Date:
- 2013-11-15
- Subjects:
- Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗ - DOI:
- 10.1111/jdv.12317 ↗
- Languages:
- English
- ISSNs:
- 0926-9959
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3007.xml